|
20.09.2024 09:15:24
|
EWTX Yields Over 300% Returns, ADMA Records 200% Gains - Did You Strike While The Iron Is Hot?
(RTTNews) - Biotech investing is a high-stakes game that may not suit the faint-hearted due to its inherent volatility. However, this sector can offer astronomical returns when investors time their entries correctly. The following biotech stocks we profiled on our site reached 52-week highs yesterday.
*Last Closing Price refers to the stock's closing price on Sep.19, 2024.
Ticker | Published Date | Published Price | Maximum Price Since Publication | *Last Closing Price | Maximum Gain % |
|---|---|---|---|---|---|
Oct.16, 2023 | $6.71 | $30.00 | $29.50 | 347% | |
Aug.14, 2024 | $8.91 | $15.23 | $15.06 | 71% | |
Feb.13, 2024 | $13.32 | $21.36 | $21.35 | 60% | |
Apr.8, 2024 | $4.47 | $6.92 | $6.70 | 55% | |
Sep.4, 2024 | $3.21 | $4.45 | $4.14 | 38% | |
Dec.1, 2023 | $33.66 | $55.64 | $54.55 | 65% | |
Sep.8, 2023 | $4.51 | $6.02 | $5.90 | 33% | |
Apr.30, 2024 | $60.61 | $121.06 | $117.12 | 99% | |
Mar.1, 2023 | $23.47 | $70.37 | $69.64 | 199% | |
Oct.27, 2022 | $62.71 | $101.26 | $100.23 | 61% | |
Feb.15, 2024 | $5.36 | $19.92 | $19.74 | 271% |
Related Reading
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rhythm Pharmaceuticals Incmehr Nachrichten
|
25.02.25 |
Ausblick: Rhythm Pharmaceuticals gibt Ergebnis zum abgelaufenen Quartal bekannt (finanzen.net) | |
|
04.11.24 |
Ausblick: Rhythm Pharmaceuticals zieht Bilanz zum abgelaufenen Quartal (finanzen.net) |
Analysen zu Rhythm Pharmaceuticals Incmehr Analysen
Aktien in diesem Artikel
| ADMA Biologics Inc | 17,02 | 0,65% |
|
| Catalyst Pharmaceutical Partners Inc. | 19,89 | 0,18% |
|
| Edgewise Therapeutics Inc Registered Shs | 28,01 | -0,43% |
|
| Eton Pharmaceuticals Inc Registered Shs | 14,59 | 1,11% |
|
| MannKind | 4,50 | 0,16% |
|
| Merit Medical Systems Inc. | 90,50 | -2,16% |
|
| RadNet IncShs | 45,80 | -2,97% |
|
| Rhythm Pharmaceuticals Inc | 45,82 | -2,27% |
|
| Travere Thereapeutics Inc Registered Shs | 18,09 | -4,49% |
|
| Vaxcyte Inc Registered Shs | 66,00 | -3,65% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.